1. Home
  2. OSW vs SRPT Comparison

OSW vs SRPT Comparison

Compare OSW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpaWorld Holdings Limited

OSW

OneSpaWorld Holdings Limited

HOLD

Current Price

$27.62

Market Cap

2.4B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$16.70

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSW
SRPT
Founded
2017
1980
Country
Bahamas
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
OSW
SRPT
Price
$27.62
$16.70
Analyst Decision
Strong Buy
Hold
Analyst Count
4
29
Target Price
$27.00
$25.85
AVG Volume (30 Days)
663.1K
2.8M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
0.21
2.88
Revenue
$961,001,000.00
$2,198,237,000.00
Revenue This Year
$7.49
N/A
Revenue Next Year
$8.52
N/A
P/E Ratio
$133.81
$5.99
Revenue Growth
7.37
15.58
52 Week Low
$19.06
$10.42
52 Week High
$28.24
$25.32

Technical Indicators

Market Signals
Indicator
OSW
SRPT
Relative Strength Index (RSI) 69.83 47.97
Support Level $19.70 $16.37
Resistance Level N/A $18.16
Average True Range (ATR) 0.93 0.76
MACD 0.35 0.31
Stochastic Oscillator 79.02 61.15

Price Performance

Historical Comparison
OSW
SRPT

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: